GLP-1 medications suppress appetite, sometimes significantly, particularly during the first few weeks of treatment and after dose increases
The medication is administered via subcutaneous injection, typically on a weekly basis, though dosing frequency and amounts may be individualized based on patient response and tolerability
Helping Patients Navigate Weight Loss Plateaus Plateaus are a natural part of weight loss, especially as the body adapts to lower calorie intake and metabolic efficiency increases
BMJ 388 , e080679 (2025)
Although substantial weight loss can reduce pathological joint loading and systemic inflammation, the direct pharmacological effects on synovial fibroblastsattenuating their inflammatory signalling and fibrotic activation may offer an additional, disease-modifying and analgesic mechanism that targets the local synovial environment, driving pain and structural progression
Eligibility, treatment recommendations, and prescriptions are determined only after provider evaluation